WORK Medical Technology Group LTD - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated October 21, 2025, reports on a corporate action taken by WORK Medical Technology Group LTD, a foreign private issuer. The primary event is the implementation of a share consolidation and an increase in authorized share capital to comply with Nasdaq listing standards.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes.
Material Changes
- Share Consolidation: On October 21, 2025, the Company implemented a 100:1 consolidation of all authorized, issued, and outstanding shares.
- Capitalization Adjustment: Pre-consolidation, there were approximately 103,591,276 shares outstanding. Post-consolidation, this reduced to approximately 1,035,913 shares outstanding (959,988 Class A and 75,925 Class B), with fractional shares rounded up.
- Authorized Capital Increase: Authorized share capital increased from US$250,000 to US$10,000,000. The new structure consists of 160,000,000 Class A shares and 40,000,000 Class B shares, each with a par value of US$0.05.
- Trading Details: Shares continue to trade under the symbol "WOK" on Nasdaq with a new CUSIP number: G9767H117.
Outlook, Risks, and Management Commentary
Reason for Action: The consolidation was executed to meet Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price and to mitigate the risk of delisting.
Compliance Timeline: The Company has until April 6, 2026, to regain full compliance with the minimum bid price requirement.
Shareholder Impact: Shareholders holding shares in electronic form did not need to take action; the consolidation was automatically reflected in brokerage accounts.
Investor Verification Checklist
- Verify the new CUSIP number (G9767H117) for accurate trading and record-keeping.
- Confirm the adjusted share count in brokerage accounts, noting that fractional shares were rounded up to whole numbers.
- Monitor the stock price to ensure it meets the Nasdaq minimum bid price requirement by the April 6, 2026 deadline.
- Review the amended and restated memorandum of association for updated governance terms related to the new capital structure.